Treatment of chronic hepatitis C with PEG-IFNalpha-2b and ribavirin: outcome for migrants from GUS countries compared to German patients within a large German multicentric observa…
S Mauss, E Zehnter, D Hüppe, M Manns, G Teuber, D Tarek, U Meyer, T Witthöft, B Möller, N Dikopoulos, J Brack, K Dach, M Bilzer, G Tossing · Zeitschrift für Gastroenterologie · 2010 · Heft 01
Bibliografische Angaben
Zusammenfassung
Aims: A combination of pegylated interferon-alfa (PEG-IFNα) plus ribavirin (RBV) is the current standard of care for treatment of chronic hepatitis C. Within a German multicentric observational study the largest group of migrants came from Ex- UdSSR countries. Since there are no larger controlled studies available comparing the treatment outcomes of migrants from GUS countries with German patients, the cohort data are of interest in order to optimize suitable treatment strategies. Methods: Between 9/2003 and 5/2009, 279 active sites treated a total of 3852 patients with weight-based PEG-IFNα-2b and RBV. They cam…
